Segall Bryant & Hamill, LLC Exact Sciences Corp Transaction History

Segall Bryant & Hamill, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $9,402 - $14,257	150 Added 4.74%	3,315 $311,000
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $149,356 - $223,987	3,165 New	3,165 $214,000
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $119,827 - $256,513	-3,365 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $20,155 - $27,989	-278 Reduced 7.63%	3,365 $261,000
Q3 2021 Nov 03, 2021	SELL	$90.24 - $124.05 $6,316 - $8,683	-70 Reduced 1.89%	3,643 $347,000
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $28,378 - $42,198	-303 Reduced 7.54%	3,713 $461,000
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $35,204 - $46,813	-302 Reduced 6.99%	4,016 $529,000
Q4 2020 Feb 12, 2021	SELL	$99.61 - $142.12 $48,808 - $69,638	-490 Reduced 10.19%	4,318 $572,000
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $350,599 - $490,464	4,808 New	4,808 $490,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.